Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 05-2005 | 05-2004 | 05-2003 | 05-2002 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 1 | 187 | 0 | N/A |
| TOTAL | $42 | $203 | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 3 | 3 | N/A | N/A |
| Intangibles | 2 | 0 | 0 | 0 |
| Other Non-Current Assets | 1 | 1 | 0 | 0 |
| TOTAL | $5 | $4 | $N/A | $N/A |
| Total Assets | $47 | $207 | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 511 | 72 | N/A | N/A |
| Accounts payable and accrued liabilities | 76 | 119 | 2 | 0 |
| Accrued Expenses | 99 | 17 | N/A | N/A |
| TOTAL | $807 | $207 | $2 | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $807 | $207 | $2 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 8,519 | 8,069 | 1,180 | N/A |
| Common Shares | 1,916 | 1,916 | 12 | N/A |
| Retained earnings | -2,717 | -1,940 | -19 | N/A |
| TOTAL | $-760 | $0 | $-1 | $N/A |
| Total Liabilities And Equity | $47 | $207 | $0 | $0 |